Kunming Longjin Pharmaceutical Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 188.250 million compared to CNY 251.725 million a year ago. Operating income was CNY 3.805 million compared to CNY 16.117 million a year ago. Net income was CNY 1.805 million compared to CNY 14.523 million a year ago. Basic earnings per share from continuing operations was CNY 0.0045 compared to CNY 0.0363 a year ago.